|
|
|
|
| LEADER |
02567nmm a2200301 u 4500 |
| 001 |
EB000710347 |
| 003 |
EBX01000000000000000563429 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9788847021198
|
| 100 |
1 |
|
|a Santori, F.S.
|e [editor]
|
| 245 |
0 |
0 |
|a Avascular Necrosis of the Femoral Head: Current Trends
|h Elektronische Ressource
|b Current Trends
|c edited by F.S. Santori, N. Santori, A. Piccinato
|
| 250 |
|
|
|a 1st ed. 2004
|
| 260 |
|
|
|a Milano
|b Springer Milan
|c 2004, 2004
|
| 300 |
|
|
|a VII, 116 p
|b online resource
|
| 505 |
0 |
|
|a Pathophysiology of Avascular Necrosis of the Femoral Head -- Avascular Necrosis: Rehabitation of Dead Bone -- Biophysical Stimulation with Pulsed Electromagnetic Fields in Avascular Necrosis of the Femur Head -- The Role of Extracorporeal Shock Waves -- Forage Biopsy plus Autologous Bone Grafting: Indications and Limits -- Long-Term Follow-Up of Free Microvascular Fibular Transfer for Idiopathic Femoral Head Necrosis -- The Rationale of a Porous Tantalum Implant in the Treatment of Early Stages of Avascular Necrosis of the Femoral Head -- Flexion Osteotomy for Idiopathic Avascular Necrosis of the Femoral Head -- Total Hip Arthroplasty in Post-Traumatic Avascular Necrosis -- Neck-Preserving Implants in the Treatment of Femoral Head Avascular Necrosis
|
| 653 |
|
|
|a Surgical Orthopedics
|
| 653 |
|
|
|a Orthopedic surgery
|
| 653 |
|
|
|a Ultrasonics
|
| 700 |
1 |
|
|a Santori, N.
|e [editor]
|
| 700 |
1 |
|
|a Piccinato, A.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 028 |
5 |
0 |
|a 10.1007/978-88-470-2119-8
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-88-470-2119-8?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 617.47
|
| 520 |
|
|
|a Avascular Necrosis (AVN) is a disease resulting from temporary or permanent loss of blood supply. It frequently affects the femoral head and in this area, if left untreated, routinely causes premature joint destruction. In the USA, 5 to 10% of cases of hip osteoarthritis requiring total hip replacement are primarily caused by AVN. In 33 to 72% of patients, the disease is bilateral. The peak incidence is between 30 and 60 years of age, and the social costs of this pathology are remarkable. There is therefore increasing interest in hip joint preserving techniques such as conservative treatment through electromagnetic fields and shockwaves as well as joint preserving surgical techniques. This volume aims to present a complete overview of the current knowledge on AVN including therapeutic options
|